ORKA - Oruka Therapeutics, Inc.
44.48
-0.980 -2.203%
Share volume: 885,714
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$45.46
-0.98
-0.02%
Summary score
41%
Profitability
35%
Dept financing
20%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-6.08%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
5.56%
Debt ratio change over timeo
0%
Current Ratio
25.41%
Quick Ratio
0%
Cash Position Ratio
19.25%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-7.05%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
4.43%
Debt ratio change over timeo
0%
Current Ratio
24.19%
Quick Ratio
0%
Cash Position Ratio
4.98%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.05%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
4.02%
Debt ratio change over time
0%
Current Ratio
22.37%
Quick Ratio
0%
Cash Position Ratio
3.05%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORKA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 26.59% | 5.85% | 19.87% |
| Return on assets | -6.08% | 9.08% | 4.56% | 20.16% |
| Return on sales | 0% | 29.31% | 19.44% | 62.23% |
| Return on invested capital | 0% | 34.79% | 11.19% | 98.59% |
| Profitability | 0% | 57% | 22% | 94% |
| Total debt ratio | 5.56% | 61.83% | 50.01% | 21.93% |
| Debt ratio change over time | 0% | 1.2% | -6.89% | -0.5% |
| Dept financing | 2% | 50% | 20% | 9% |
| Current Ratio | 24.19% | 1.17% | 3.85% | 0% |
| Quick Ratio | 0% | 0.84% | 3.63% | 0% |
| Cash Position Ratio | 4.98% | 0.15% | 2.11% | 0% |
| Liquididy | 50% | 7% | 29% | 33% |
| Short-term ratios | ORKA | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -7.05% | 10.24% | 3.99% | 0% |
| Return on sales | 0% | 31.59% | 13.8% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 21% | 0% |
| Total debt ratio | 4.43% | 54.28% | 47.53% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 25% | 22% | 0% |
| Current Ratio | 24.19% | 1.17% | 3.85% | 0% |
| Quick Ratio | 0% | 0.84% | 3.63% | 0% |
| Cash Position Ratio | 4.98% | 0.15% | 2.11% | 0% |
| Liquididy | 50% | 8% | 40% | 0% |